drugset / Trial / NCT03684707

Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions

NCT03684707 ↗

Phase 4 Unknown 30 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindPrevention

Summary

Evaluation of the metformin drug effect as a drug that found to improve the quality of tissues, decrease signs \& symptoms of cancer, and decrease histo-pathological criteria of dysplasia. This will be done by the aid of measuring salivary Micro RNA 31 \& 210 in saliva in addition to measure cyclin A2 as an immuno-histochemical analysis.

Timeline

Start
2018-09-15
Primary completion
2019-06-15
Completion
2019-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 500 mg —

Indications